// App-Quantinova.ai

451 : Fibrin Crosslinking Is Required For Retention Of Red Blood Cells In Venous Thrombi

Researchers

Presenter

  • Maria M. Aleman

Principal Investigators

  • James R. Byrnes

  • Jianguo Wang

  • Nigel Mackman

  • Jay L. Degen

  • Matthew J Flick

  • Alisa S. Wolberg

Medical Centers

  • Division of Experimental Hematology and Cancer Biology, Cincinnati Childrens Hospital Medical Center, Cincinnati, OH

  • Division of Rheumatology, Cincinnati Children's Hospital Medical Center and The University of Cincinnati College of Medicine, Cincinnati, OH

  • UNC McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC

  • Dept of Pathology and Laboratory Medicine, University of North Carolina Chapel Hill, Durham, NC

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Venous thrombosis

  • Inflammatory Arthritis

  • Ulcerative colitis

Biomarkers

  • Alpha-tubulin N-acetyltransferase 1

  • Red Blood Cells

Drug/Treatment

  • Fibrinogen (IV)

  • Evithrom

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim